Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

BACKGROUND: Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Radiol Oncol
Главные авторы: Schmitz, Sandra, Rommel, Denis, Michoux, Nicolas, Lhommel, Renaud, Hanin, François-Xavier, Duprez, Thierry, Machiels, Jean-Pascal
Формат: Artigo
Язык:Inglês
Опубликовано: Versita, Warsaw 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362602/
https://ncbi.nlm.nih.gov/pubmed/25810697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2014-0030
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы